ipriflavone has been researched along with Cognition Disorders in 1 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, J | 2 |
| Zhu, Y | 1 |
1 other study available for ipriflavone and Cognition Disorders
| Article | Year |
|---|---|
Effects of estrogen and estrogenic compounds on cognition in ovariectomized rats.
Topics: Animals; Cognition; Cognition Disorders; Estradiol; Estrogen Receptor Modulators; Female; Humans; Is | 2008 |